The Pain Intensity of the Patients Who Had Undergone Abdominal Surgery With a Midline Incision

Not Applicable

Completed

• Conditions: Transcutaneous Electric Nerve Stimulation
• Interventions: Other: TENS; Other: TAES

• Registration Number: NCT03762486
• Lead Sponsor: Yuksek Ihtisas University

Brief Summary

The purpose of this study is to determine the effects of transcutaneous electrical nerve stimulation (TENS) and transcutaneous acupoint electrical stimulation (TAES) on pain and analgesic drug consumption in patients who had undergone abdominal surgery with a midline incision. Evidence for the effects of and transcutaneous electrical stimulation on pain and analgesic consumption on patients undergoing abdominal surgery with severe pain experience and high levels of neuroendocrine stress response is uncertain.

Detailed Description

This research was conducted as a randomized controlled trial. 158 patients who had undergone abdominal surgery with diagnosis of gastric and colorectal cancer were assessed for eligibility. This research sample consisted of 48 patients who underwent abdominal surgery with a midline incision. The patients were randomized into three groups, the first intervention group, which used TENS (around the incision), the second intervention group, which used TAES (ST25, P6, ST36, Lİ4 acupuncture points) and the control group, which did not. Electric stimulation was performed at the 30th minute, second, 18th, 21st, 40th, and 45th hours after the operation. Pain scores and analgesic consumption were assessed in the first 48 hours after surgical intervention.

Study Timeline

• Study Start: 2015-05-12
• Primary Completion: 2016-11-30
• Study Completion: 2016-11-30
• Study First Submitted: 2018-01-05
• Status Verified: 2018-03
• Study First Submitted QC: 2018-11-30
• Last Update Submitted: 2018-11-30
• Study First Posted: 2018-12-03
• Last Update Posted: 2018-12-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• Patients who had an American Society of Anesthesiologists (ASA) score of I-II
• Patients were aged over 18 years
• Patients who could read and write Turkish
• Patients who were scheduled to undergo elective abdominal surgery with a midline incision for a diagnosis of stomach or colorectal cancer
• Patients without any impairment of vision, hearing or speech

Exclusion Criteria

• Patients who had a pacemaker
• Patients whose skin integrity around the incision was degraded
• Patients had a cognitive disorder, had a history of chronic pain, or were suffering from neurological, renal, cardiac or pulmonary disorders that could affect the test results
• Patients with an opioid addiction
• Patients those who had previously undergone electrical stimulation treatment
• Morbidly obese subjects
• Patients using psychoactive drugs

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Arm && Interventions

Group	Intervention	Description
TENS to around the incision	TENS	The Patient Controlled Analgesia infusion was started right after the surgery. TENS was applied to around the incision.
TAES to the acupuncture points	TAES	The Patient Controlled Analgesia infusion was started right after the surgery. TAES was applied to acupuncture points.

Primary Outcome Measures

Name	Time	Method
Postoperative pain intensity	The pain levels were evaluated and compared within postoperative first 48 hours.	First Intervention Group: Electrical stimulation was implemented at the 30th minute and 2, 18, 22, 42, and 46th hours after the surgery.; Second Intervention Group: Electrical stimulation was implemented at acupuncture points of the patients at the 30th minute and 2, 18, 22, 42, and 46th hours after the surgery.; Control Group: No intervention was performed to the patients in the control group.; The pain intensity of each groups' patients were recorded and compred at the post-operative 2, 18, 22, 42, and 46th hours. Pain intensity was evaluated with VAS. VAS with a range of 1-10 points was used while evaluating the pain intensity of all patients .The increase of the scale score shows that the pain intensity increases.

Secondary Outcome Measures

Name	Time	Method
Antiemetic drug consumption	Antiemetic drug consumption of the patients was evaluated at the periods of 0-24 and 24-48 hours. Patients were assessed in postoperative first 48 hours.	The antiemetic drug amount administered to the patients was recorded in mg.
Nausea severity	The nausea severity of the patients were evaluated at the periods of 0-6, 6-24, 24-48 hours. Patients were assessed in postoperative first 48 hours.	VAS with a range of 1-10 points was used while evaluating the nausea severity of all patients .The increase of the scale score shows that the nausea severity increases.
Analgesic drug consumption	Analgesic drug consumption of the patients was evaluated at the periods of 0-24 and 24-48 hours. Patients were assessed in postoperative first 48 hours.	All patients were administered intravenous tramadol hydrochloride infusion with the Patient Controlled Analgesia for the first 48 hours. Dexketoprofen trometamol vial intravenous and/or 50 mg. Pethidine hydrochloride intramuscular was used as the rescue analgesic.
Pulmonary function tests	Pulmonary function evaluations of the patients were performed at the 24th and 48th hours. Patients were assessed in postoperative first 48 hours.	The pulmonary functions of the patients were evaluated with a portable spirometer. Peak expiratory flow (PEF) and forced vital capacity (FVC) values were recorded. The measurement of respiratory functions was performed with the patient wrapping the disposable mouthpiece well with the lips during the measurement. The patient was asked to breathe deeply and exhale suddenly and quickly. This process was repeated three times and the best performance was taken as the base value.
Vomiting	Vomiting status of the patients were evaluated at the periods of 0-6, 6-24, 24-48 hours. Patients were assessed in postoperative first 48 hours.	Vomiting: The number of times the patients vomited was recorded